- Published on
Medicine – Orbital Cellulitis
Orbital cellulitis is an acute, potentially sight- and life-threatening infection involving the soft tissues posterior to the orbital septum. It must be distinguished from preseptal cellulitis, which is confined to tissues anterior to the orbital septum and generally does not cause proptosis, painful/restricted eye movements, optic nerve dysfunction, or other orbital signs.
Orbital cellulitis is a medical emergency because infection can rapidly threaten vision and can spread posteriorly into the cavernous sinus or intracranial cavity.
1. Definition
Orbital cellulitis is an infection of the:
Orbital soft tissues behind the orbital septum.
Inflammation can involve:
Orbital fat.
Extraocular muscles.
Neurovascular structures.
Optic nerve and surrounding tissues.
The resulting oedema and inflammation increase orbital pressure and may compromise ocular movement, retinal/optic nerve perfusion and vision.
2. Epidemiology
Orbital cellulitis is relatively uncommon but occurs particularly in:
Children.
It may also occur in adolescents and adults.
The exact incidence varies among populations, so older numerical estimates should not be treated as universal.
3. Major Risk Factors
The most important risk factor is:
Acute bacterial sinusitis.
Other important risk factors include:
Periocular or orbital trauma.
Recent orbital or sinus surgery.
Skin or eyelid infection.
Dacryocystitis.
Dental infection.
Immunosuppression.
Poorly controlled diabetes, particularly when invasive fungal infection is possible.
4. Sinusitis – The Major Cause
Most cases arise from extension of infection from the:
Paranasal sinuses.
The most important sinus, particularly in children, is the:
Ethmoid sinus.
Therefore:
ETHMOID SINUSITIS → ORBITAL CELLULITIS
is the classic association.
5. Why Ethmoid Sinusitis Spreads to the Orbit
The ethmoid sinus is separated from the orbit by an extremely thin medial orbital wall called the:
Lamina papyracea.
Infection can therefore spread relatively easily from the ethmoid sinus into the orbit.
Communication through venous channels also facilitates spread because the orbital and facial venous systems contain important:
Valveless venous connections.
6. Routes of Infection
Orbital cellulitis can develop through several routes.
The commonest is:
Direct extension from sinusitis.
Other routes include:
Extension from preseptal or facial infection.
Dacryocystitis.
Dental infection.
Penetrating orbital trauma.
Orbital surgery.
Spread from ocular infection.
Rarely:
Haematogenous spread during bacteraemia.
7. Pathophysiology
Once infection enters the orbit, it produces:
Inflammation + oedema + increased orbital pressure.
Because the orbit is a relatively confined bony compartment, increasing tissue volume can cause:
Proptosis.
Restricted extraocular movement.
Pain.
Elevated intraocular pressure.
Optic nerve compromise.
8. Subperiosteal Abscess
Infection spreading from the ethmoid sinus may collect between the orbital wall and periosteum.
This produces a:
Subperiosteal orbital abscess.
It commonly develops along the:
Medial orbital wall.
This is an important complication because some abscesses require surgical drainage.
9. Orbital Abscess
More extensive infection can produce a true:
Orbital abscess.
An orbital abscess can cause rapidly increasing orbital pressure and may threaten:
The optic nerve and vision.
The presence of an abscess is an important factor when deciding whether surgical drainage is required.
10. Causative Organisms
Orbital cellulitis is usually:
Bacterial.
The organisms depend on factors such as:
Age.
Underlying sinus disease.
Previous antibiotic exposure.
Trauma.
Local resistance patterns.
Immune status.
11. Common Bacterial Organisms
Important organisms include:
Staphylococcus aureus, including MRSA where epidemiologically relevant.
Streptococcus species.
Streptococcus pneumoniae.
Other respiratory and anaerobic organisms may participate, especially when infection originates from the:
Sinuses or teeth.
12. Polymicrobial Infection
Older children and adults, particularly those with complicated sinus or dental infections, may have:
Polymicrobial infection.
This can include:
Aerobic bacteria
and
Anaerobic bacteria.
For this reason, empirical treatment generally requires:
Broad-spectrum intravenous antibiotics.
13. Fungal Orbital Infection
Fungal infection is much less common but extremely important.
Major organisms include:
Mucorales causing mucormycosis
and
Aspergillus species.
14. Mucormycosis
Rhino-orbital-cerebral mucormycosis should particularly be considered in patients with:
Poorly controlled diabetes, especially ketoacidosis,
or
Significant immunosuppression.
The fungus can invade blood vessels, causing:
Thrombosis.
Tissue ischaemia.
Necrosis.
Rapid orbital and intracranial spread.
15. Clinical Presentation
Orbital cellulitis usually presents acutely over:
Hours to several days.
Patients may initially have:
Sinusitis or an upper respiratory infection
followed by increasing:
Periorbital swelling.
Redness.
Pain.
16. Eyelid Swelling
Prominent:
Eyelid oedema and erythema
are common.
However, eyelid swelling alone does not distinguish orbital cellulitis from:
Preseptal cellulitis.
The diagnosis becomes much more concerning when true orbital signs appear.
17. Painful or Restricted Eye Movement
One of the most important clinical features is:
Pain with eye movement
and/or
Restricted extraocular movements – ophthalmoplegia.
This occurs because the orbital inflammatory process involves or mechanically restricts:
Extraocular muscles and surrounding orbital tissues.
Therefore:
PAINFUL/RESTRICTED EYE MOVEMENTS → THINK POSTSEPTAL ORBITAL DISEASE.
18. Diplopia
Restricted extraocular movements may produce:
Diplopia.
The patient may complain of double vision, although severe eyelid swelling can make this difficult to assess.
19. Proptosis
Proptosis means forward displacement of the globe.
It occurs because inflammatory tissue and oedema increase the volume of orbital contents.
Therefore:
PROPTOSIS + PAINFUL/RESTRICTED EYE MOVEMENTS
is a major warning combination for:
Orbital cellulitis.
20. Conjunctival Chemosis
The conjunctiva may become markedly oedematous, producing:
Chemosis.
There may also be:
Conjunctival injection.
These findings reflect orbital venous congestion and inflammation.
21. Reduced Vision
Visual acuity may decrease if orbital inflammation compromises:
The optic nerve
or
Ocular perfusion.
Reduced vision is particularly concerning because it may indicate:
Sight-threatening orbital disease.
22. Pupillary Abnormalities
Optic nerve dysfunction may cause:
Relative afferent pupillary defect – RAPD.
The pupil may also respond sluggishly.
An RAPD in orbital cellulitis should raise concern for:
Optic nerve compromise.
23. Raised Intraocular Pressure
Orbital congestion and increased pressure may increase:
Intraocular pressure – IOP.
This is another indication of significant orbital involvement.
24. Systemic Features
Patients may also develop:
Fever.
Malaise.
Headache.
Systemic toxicity.
However, absence of fever does not exclude orbital cellulitis.
25. Red-Flag Features
Particularly concerning findings include:
Reduced visual acuity.
RAPD.
Proptosis.
Painful or restricted ocular movement.
Diplopia.
Marked chemosis.
Severe headache.
Altered consciousness.
These findings require urgent specialist assessment.
26. Orbital Cellulitis Versus Preseptal Cellulitis – Note Form
Preseptal cellulitis:
Infection anterior to orbital septum.
Eyelid swelling and erythema.
Vision generally preserved.
Eye movements generally normal.
No true proptosis.
No RAPD from orbital optic nerve compromise.
Orbital cellulitis:
Infection posterior to orbital septum.
Proptosis may occur.
Painful/restricted eye movements.
Diplopia.
Chemosis.
Vision may decrease.
RAPD may develop.
Potential intracranial complications.
Therefore:
PROPTOSIS + OPHTHALMOPLEGIA/PAINFUL EYE MOVEMENT + VISUAL DYSFUNCTION → ORBITAL CELLULITIS.
27. Diagnosis
Orbital cellulitis is primarily a:
Clinical diagnosis supported by imaging.
Assessment should establish:
Visual acuity.
Pupillary responses.
Colour vision when feasible.
Ocular motility.
Proptosis.
Intraocular pressure when appropriate.
Fundus/optic nerve status when examination permits.
These findings should be documented and monitored because deterioration may indicate:
Optic nerve compromise or abscess progression.
28. Blood Tests
Investigations commonly include:
Full blood count.
Inflammatory markers such as CRP.
Other investigations depend on severity and clinical context.
29. Microbiology
If appropriate material is available, microbiological samples may be obtained from:
Purulent discharge.
Sinus material.
Surgically drained abscess material.
Blood cultures may be useful particularly in patients with:
Fever, systemic toxicity or suspected bacteraemia.
Deep surgical specimens are generally more informative than superficial swabs.
30. CT Imaging
When imaging is indicated, contrast-enhanced CT of the orbits and paranasal sinuses is commonly used because it rapidly demonstrates:
Orbital inflammation.
Sinusitis.
Subperiosteal abscess.
Orbital abscess.
Bony anatomy.
Possible extension of infection.
The older statement that CT is always the absolute “gold standard” is better replaced by:
CT is usually the first-line urgent imaging modality when orbital cellulitis or its complications require imaging.
31. MRI
MRI provides excellent assessment of:
Orbital soft tissues.
Optic nerve.
Orbital apex.
Intracranial structures.
It may be particularly useful when there is concern about:
Intracranial extension
or
Cavernous sinus thrombosis.
32. MR Venography
If cerebral venous or cavernous sinus thrombosis is suspected, vascular imaging such as:
MR venography
may be required depending on the clinical situation and local protocol.
33. Differential Diagnosis
Important differential diagnoses include:
Preseptal cellulitis.
Idiopathic orbital inflammatory disease.
Dacryoadenitis.
Dacryocystitis.
Thyroid eye disease.
Orbital tumour.
Orbital haemorrhage.
Herpes zoster ophthalmicus.
Allergic eyelid swelling.
34. Treatment – Medical Emergency
Orbital cellulitis should generally be managed as an:
Emergency requiring hospital admission.
Treatment should not be delayed when the clinical diagnosis is strongly suspected.
The major goals are to:
Control infection.
Preserve vision.
Treat the underlying sinus source.
Identify and drain abscesses when necessary.
Prevent intracranial spread.
35. Intravenous Antibiotics
Initial treatment consists of:
Broad-spectrum intravenous antibiotics.
Empirical therapy should cover the major likely organisms, including:
Staphylococci.
Streptococci.
Relevant gram-negative organisms.
Anaerobes when indicated.
MRSA coverage is added when clinically or epidemiologically appropriate.
36. Antibiotic Selection
The exact antibiotic regimen should depend on:
Age.
Severity.
Likely source.
Allergy history.
Local antimicrobial resistance.
Culture results.
Immune status.
Therefore, older fixed antibiotic lists should not be interpreted as universally appropriate treatment protocols.
Common contemporary regimens may use a broad-spectrum beta-lactam or cephalosporin-based regimen, with:
Vancomycin when MRSA coverage is required
and additional anaerobic coverage when necessary.
37. Important Antibiotic Update
The original text lists:
Aminoglycosides and fluoroquinolones
among possible IV therapies.
These are not generally the universal first-line backbone for uncomplicated orbital cellulitis.
Modern treatment is better conceptualised as:
BROAD-SPECTRUM IV THERAPY TAILORED TO LOCAL GUIDELINES AND THE SUSPECTED SOURCE.
38. Specialist Involvement
An:
Ophthalmologist
should be involved urgently.
Because sinusitis is frequently responsible, an:
ENT specialist
is also commonly involved.
Severe intracranial disease may require additional:
Neurosurgical or infectious-disease input.
39. Close Visual Monitoring
Vision should be assessed repeatedly during treatment.
Important parameters include:
Visual acuity.
Pupillary responses/RAPD.
Colour vision when possible.
Eye movements.
Proptosis.
Orbital signs.
Deterioration can indicate:
Increasing orbital pressure or optic nerve compromise.
40. Surgical Treatment
Not every patient requires orbital surgery.
Surgical drainage should be considered when there is:
Orbital abscess.
Significant or enlarging subperiosteal abscess in an appropriate clinical setting.
Visual deterioration.
Optic nerve compromise.
Failure to improve or clinical deterioration despite appropriate IV antibiotics.
Suspected fungal infection.
Foreign body or other surgically correctable source.
41. Sinus Surgery
Because sinusitis is frequently the source, surgery may involve:
Endoscopic sinus drainage
with or without:
Orbital/subperiosteal abscess drainage.
The decision depends on the location and size of the collection, patient age, visual function, causative organism and response to antibiotics.
42. Corticosteroids
The original text describes corticosteroids as controversial.
That remains a useful caution.
Systemic corticosteroids may sometimes be considered as an:
Adjunct after appropriate antimicrobial treatment has begun and infection is being controlled.
They should never replace antibiotics, and their use requires specialist judgement.
They are particularly inappropriate as empiric treatment when:
Invasive fungal infection has not been excluded in a high-risk patient.
43. Suspected Mucormycosis
Suspected rhino-orbital-cerebral mucormycosis requires:
Immediate specialist management.
Treatment generally involves:
Urgent systemic antifungal therapy
plus
Aggressive surgical debridement when indicated
and correction of underlying factors such as:
Hyperglycaemia or ketoacidosis.
Delay can be catastrophic.
44. Response to Treatment
Clinical improvement is assessed primarily through:
Symptoms.
Visual function.
Ocular motility.
Proptosis.
Swelling.
Systemic condition.
Radiological abnormalities may resolve more slowly than clinical symptoms.
Therefore routine repeated imaging is not always required in a patient who is:
Clearly improving clinically.
45. When Repeat Imaging Is Useful
Repeat imaging becomes more important when the patient:
Deteriorates.
Fails to improve as expected.
Develops new visual dysfunction.
Develops neurological symptoms.
Is suspected of developing an abscess or intracranial complication.
46. Duration of Antibiotics
The original text gives approximately:
Two weeks of total antibiotic therapy.
Treatment duration should instead be:
Individualised.
It depends on:
Clinical response.
Extent of sinus/orbital disease.
Presence of abscess.
Surgical findings.
Causative organism.
Intracranial involvement.
Patients may transition from IV to oral therapy once sufficiently improved and when clinically appropriate.
47. Cavernous Sinus Thrombosis
One of the most feared complications is:
Cavernous sinus thrombosis.
Orbital and facial infections can spread through:
Valveless venous channels
toward the cavernous sinus.
Features Suggesting Cavernous Sinus Involvement
Possible findings include:
Severe headache.
Fever and toxicity.
Increasing proptosis.
Ophthalmoplegia.
Cranial nerve III, IV, V₁, V₂ or VI abnormalities.
Bilateral orbital involvement.
Neurological deterioration.
This is a life-threatening emergency.
48. Optic Nerve Injury and Blindness
Orbital inflammation may compromise the optic nerve through:
Compression.
Ischaemia.
Inflammation.
Therefore severe orbital cellulitis can result in:
Permanent visual loss or blindness.
This explains why repeated visual assessment is central to management.
49. Intracranial Complications
Infection can spread beyond the orbit and cause:
Meningitis.
Brain abscess.
Subdural or epidural infection.
Cavernous sinus thrombosis.
Sepsis.
Rarely:
Death.
50. Complications – Note Form
Ocular:
Optic neuropathy.
Permanent visual loss.
Orbital/subperiosteal abscess.
Exposure-related ocular injury.
Venous:
Cavernous sinus thrombosis.
Intracranial:
Meningitis.
Brain abscess.
Other intracranial suppurative complications.
Systemic:
Sepsis.
Rarely death.
51. Prognosis
With early recognition, appropriate antibiotics, imaging and multidisciplinary treatment, the prognosis is generally:
Good.
However, delayed diagnosis or inadequate treatment can result in severe:
Visual, neurological and systemic complications.
52. Important Updates to the Original Text
The most useful definition is:
ORBITAL CELLULITIS = INFECTION POSTERIOR TO THE ORBITAL SEPTUM.
This immediately helps distinguish it from preseptal cellulitis.
The statement that CT is simply the “gold standard” should be refined:
CONTRAST-ENHANCED CT OF THE ORBITS AND SINUSES IS COMMONLY THE FIRST-LINE URGENT IMAGING TEST WHEN IMAGING IS NEEDED.
MRI is particularly valuable for:
Soft-tissue, orbital apex, cavernous sinus and intracranial complications.
Antibiotic treatment should not be memorised as a fixed historical list.
Instead remember:
BROAD-SPECTRUM IV ANTIBIOTICS + APPROPRIATE MRSA/ANAEROBIC COVERAGE ACCORDING TO CLINICAL CONTEXT AND LOCAL GUIDELINES.
Surgery is not required simply because sinusitis is present.
Surgical intervention becomes particularly important with:
ABSCESS + VISUAL COMPROMISE + CLINICAL DETERIORATION/FAILURE TO IMPROVE + INVASIVE FUNGAL DISEASE.
Key Clinical Pattern
The most important distinction to remember is:
PRESEPTAL CELLULITIS → EYELID REDNESS/SWELLING BUT NORMAL EYE MOVEMENTS, NO TRUE PROPTOSIS AND PRESERVED ORBITAL FUNCTION.
ORBITAL CELLULITIS → PAINFUL/RESTRICTED EYE MOVEMENTS + PROPTOSIS ± DIPLOPIA/CHEMOSIS/VISUAL IMPAIRMENT.
The classic sequence is:
ETHMOID SINUSITIS
↓
SPREAD THROUGH THIN MEDIAL ORBITAL WALL
↓
ORBITAL INFECTION
↓
OEDEMA + PROPTOSIS + PAINFUL OPHTHALMOPLEGIA
↓
POSSIBLE OPTIC NERVE COMPROMISE / ABSCESS
↓
POSSIBLE CAVERNOUS SINUS OR INTRACRANIAL SPREAD.
Therefore, for rapid exam recall:
CHILD + SINUSITIS + SWOLLEN RED EYE + PROPTOSIS + PAINFUL/RESTRICTED EYE MOVEMENTS = ORBITAL CELLULITIS UNTIL PROVEN OTHERWISE.
REDUCED VISION OR RAPD = SIGHT-THREATENING ORBITAL INVOLVEMENT.
ORBITAL CELLULITIS = ADMIT + URGENT IV ANTIBIOTICS + OPHTHALMOLOGY ± ENT + IMAGING/SURGERY AS INDICATED.